We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current AADI market cap is 44.81M. The company's latest EPS is USD -2.6784 and P/E is -0.68.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.25M | 5.23M | 5.87M | 6.2M | 5.96M |
| Operating Income | -15.04M | -15.47M | -16.83M | -19.55M | -17.85M |
| Net Income | -14.47M | -13.91M | -15.22M | -17.97M | -16.3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 15M | 1.12M | 15.22M | 24.35M |
| Operating Income | -24.44M | -6.36M | -111.22M | -62.68M | -71.93M |
| Net Income | -23.27M | -4.32M | -220.18M | -60.51M | -65.77M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 194.1M | 184.24M | 170.65M | 151.23M | 139.66M |
| Total Liabilities | 25M | 25.86M | 24.67M | 19.81M | 21.46M |
| Total Equity | 169.11M | 158.38M | 145.99M | 131.42M | 118.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 39.94M | 44.93M | 157.91M | 184.24M | 132.42M |
| Total Liabilities | 3.4M | 1.87M | 21.5M | 25.86M | 27.23M |
| Total Equity | 36.54M | 43.06M | 136.41M | 158.38M | 105.2M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -38.33M | -49.64M | -21.31M | -38.07M | -50.02M |
| Investing | -48.51M | -132.89M | 16.33M | 66.89M | 79.56M |
| Financing | 72.73M | 72.61M | 8k | 321k | 246k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -23.85M | -5.39M | -22.42M | -49.64M | -59.66M |
| Investing | -237k | -19k | 25.15M | -132.89M | 83.21M |
| Financing | N/A | 9.48M | 141.8M | 72.61M | 326k |
| Market Cap | 44.81M |
| Price to Earnings Ratio | -0.68 |
| Price to Sales Ratio | 1.84 |
| Price to Cash Ratio | 0.71 |
| Price to Book Ratio | 0.42 |
| Dividend Yield | - |
| Shares Outstanding | 24.55M |
| Average Volume (1 week) | 156.54k |
| Average Volume (1 Month) | 226.62k |
| 52 Week Change | -77.58% |
| 52 Week High | 8.60 |
| 52 Week Low | 1.55 |
| Spread (Intraday) | 0.01 (0.55%) |
| Company Name | Aadi Bioscience Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aadibio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
